|
1.888.DUI.CHARGE
1.888.384.2427
|
||||
|
||||
|
ILLEGAL DRUGS / CONTROLLED SUBSTANCES Controlled
Substances Act (CSA)
The CSA places all substances that are regulated under existing federal law into one of five schedules. This placement is based upon the substance's medicinal value, harmfulness, and potential for abuse or addiction. Schedule I is reserved for the most dangerous drugs that have no recognized medical use, while Schedule V is the classification used for the least dangerous drugs. The act also provides a mechanism for substances to be controlled, added to a schedule, decontrolled, removed from control, rescheduled, or transferred from one schedule to another. Punishment for violations of the law are severe, especially for Schedule I and Schedule II drugs, which are “100% contraband” (Schedule I) or “conditionally contraband” absent approved DEA use by those holing a permit (Schedule II). Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS), or by petition from any interested party, including the manufacturer of a drug, a medical society or association, a pharmacy association, a public interest group concerned with drug abuse, a state or local government agency, or an individual citizen. When a petition is received by the DEA, the agency begins its own investigation of the drug. The DEA also may begin an investigation of a drug at any time based upon information received from law enforcement laboratories, state and local law enforcement and regulatory agencies, or other sources of information. Once the DEA has collected the necessary data, the DEA Administrator, by authority of the Attorney General, requests from the HHS a scientific and medical evaluation and recommendation as to whether the drug or other substance should be controlled or removed from control. This request is sent to the Assistant Secretary of Health of the HHS. Then, the HHS solicits information from the Commissioner of the Food and Drug Administration and evaluations and recommendations from the National Institute on Drug Abuse, and on occasion, from the scientific and medical community at large. The Assistant Secretary, by authority of the Secretary, compiles the information and transmits back to the DEA a medical and scientific evaluation regarding the drug or other substance, a recommendation as to whether the drug should be controlled, and in what schedule it should be placed. The medical and scientific evaluations are binding to the DEA with respect to scientific and medical matters. The recommendation on scheduling is binding only to the extent that if HHS recommends that the substance not be controlled, the DEA may not control the substance. Once the DEA has received the scientific and medical evaluation from HHS, the Administrator will evaluate all available data and make a final decision whether to propose that a drug or other substance be controlled and into which schedule it should be placed. The
CSA also creates a closed system of distribution for those authorized
to handle controlled substances. The cornerstone of this system
is the registration of all those authorized by the DEA to handle
controlled substances. All individuals and firms that are registered
are required to maintain complete and accurate inventories and records
of all transactions involving controlled substances, as well as
security for the storage of
Dove
E
Elephant (White)
Euro (White)
Euro (Orange) Contraband Drugs and
United States Law Schedule
I (MOST CONTROLLED OF ALL SUBSTANCES/DRUGS)
FEDERAL
Schedule I shall consist of the drugs and other substances,
by whatever official name, common or usual name, chemical
name, or brand name designated, listed in this section. Each
drug or substance has been assigned the DEA Controlled Substances
Code Number set forth opposite it. For
federal penalty ranges, see:
STATE
STATE
definition of Schedule I drugs: (Georgia) (A)
The drug or other substance has a high potential for abuse; (B)
The drug or other substance has no currently accepted medical
use in treatment in the United States; and (C)
There is a lack of accepted safety for use of the drug or
other substance under medical supervision.
Schedule
II
|
|
Disclaimer and Terms of Use Counties |